BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6609240)

  • 21. Increased thymocyte differentiation in myasthenia gravis: a dual-color immunofluorescence phenotypic analysis.
    Durelli L; Massazza U; Poccardi G; Ferrio MF; Cavallo R; Maggi G; Casadio C; Di Summa M; Bergamini L
    Ann Neurol; 1990 Feb; 27(2):174-80. PubMed ID: 2317013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the thymus from patients with multiple sclerosis and myasthenia gravis.
    Trotter JL; Ferguson TF; Garvey WF
    J Neuroimmunol; 1982 Oct; 3(2):99-111. PubMed ID: 6181094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Reaction between myasthenia patients' sera and the antigenic structure of the surface of thymic lymphocytes of healthy subjects and myasthenia gravis patients].
    Gnezditskaia EV; Beletskaia LV; Ippolitov IKh; Malkina LA; Shagal DI
    Biull Eksp Biol Med; 1980 Oct; 90(10):462-4. PubMed ID: 7000198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical study of thymic B cells in myasthenia gravis and ulcerative colitis.
    Yokono H; Hibi T; Fujisawa T; Suzuki T; Ohbu M; Muraoka M; Tsuchiya M; Hata J
    Acta Pathol Jpn; 1993; 43(7-8):386-95. PubMed ID: 8372684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibody analysis of blood T-cell subsets in myasthenia gravis.
    Skolnik PR; Lisak RP; Zweiman B
    Ann Neurol; 1982 Feb; 11(2):170-6. PubMed ID: 6462101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double labelled T suppressor lymphocytes in the thymus of a patient with myasthenia gravis: morphological and immunological characteristics.
    Bárdosi L; Ambrus M; Koltay M; Karlinger GT; Gellért M
    J Clin Lab Immunol; 1982 Jan; 7(1):75-80. PubMed ID: 6461769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Abnormal T cell maturation in myasthenia gravis associated thymomas].
    Nenninger R; Schultz A; Müller-Hermelink HK; Marx A
    Verh Dtsch Ges Pathol; 1996; 80():256-60. PubMed ID: 9065022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunohistochemical study of thymus in patients with congenital heart disease or rheumatic heart disease].
    Ge ZH; Wang RY; Li BH; Xie WQ; Wan GG
    Shi Yan Sheng Wu Xue Bao; 1990 Jun; 23(2):193-203. PubMed ID: 2375206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of positive selection of thymoma-associated T cells in the pathogenesis of myasthenia gravis.
    Inada K; Okumura M; Shiono H; Inoue M; Kadota Y; Ohta M; Matsuda H
    J Surg Res; 2005 Jun; 126(1):34-40. PubMed ID: 15916972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
    Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
    Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upregulation of Bcl-2 protein in the myasthenic thymus.
    Onodera J; Nakamura S; Nagano I; tobita M; Yoshioka M; Takeda A; Oouchi M; Itoyama Y
    Ann Neurol; 1996 Apr; 39(4):521-8. PubMed ID: 8619530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical examinations of thymic abnormalities and significance of thymectomy in the patients with autoimmune disease].
    Yoshimatsu H; Ishikura Y; Odagiri S; Mizoguchi Y
    Rinsho Kyobu Geka; 1989 Jun; 9(3):267-72. PubMed ID: 9301928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered expression of Th1-type chemokine receptor CXCR3 on CD4+ T cells in myasthenia gravis patients.
    Suzuki Y; Onodera H; Tago H; Saito R; Ohuchi M; Shimizu M; Matsumura Y; Kondo T; Yoshie O; Itoyama Y
    J Neuroimmunol; 2006 Mar; 172(1-2):166-74. PubMed ID: 16427705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphocyte subpopulations in thymus and blood from patients with myasthenia gravis.
    Aarli JA; Heimann P; Matre R; Thunold S; Tönder O
    J Neurol Neurosurg Psychiatry; 1979 Jan; 42(1):29-34. PubMed ID: 310870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of T cell subsets in myasthenia gravis using anti-T cell monoclonal antibodies.
    Berrih S; Gaud C; Bach MA; Le Brigand H; Binet JP; Bach JF
    Clin Exp Immunol; 1981 Jul; 45(1):1-8. PubMed ID: 6458432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphocyte subpopulations in non-neoplastic thymus from myasthenia gravis patients.
    Piantelli M; Musiani P; Lauriola L; Carbone A; Tonali P; Dina MA
    Clin Exp Immunol; 1980 Jul; 41(1):19-24. PubMed ID: 6969152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune regulation in myasthenia gravis: evidence for an increased suppressor T-cell population.
    Miller AE; Hudson J; Tindall RS
    Ann Neurol; 1982 Oct; 12(4):341-7. PubMed ID: 6216848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mononuclear cell subsets in the peripheral blood of patients with myasthenia gravis].
    Bu B
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Jun; 23(3):140-2, 188-9. PubMed ID: 1975232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of poliovirus-infected macrophages in thymus of patients with myasthenia gravis.
    Cavalcante P; Barberis M; Cannone M; Baggi F; Antozzi C; Maggi L; Cornelio F; Barbi M; Didò P; Berrih-Aknin S; Mantegazza R; Bernasconi P
    Neurology; 2010 Apr; 74(14):1118-26. PubMed ID: 20368632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seronegative myasthenia gravis and Graves' disease. Is there a link?
    Polymeris A; Karoutsou E; Doumouchtsis K
    Exp Clin Endocrinol Diabetes; 2012 May; 120(5):254-6. PubMed ID: 22421982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.